Insider Transactions in Q1 2023 at Vor Biopharma Inc. (VOR)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2023
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,657
-1.77%
|
$63,285
$5.51 P/Share
|
|
Mar 01
2023
|
Nathan D. Jorgensen CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
6,310
-3.92%
|
$31,550
$5.51 P/Share
|
|
Mar 01
2023
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
5,576
-3.77%
|
$27,880
$5.51 P/Share
|
|
Feb 06
2023
|
Robert Ang PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
128,750
+15.29%
|
-
|
|
Feb 06
2023
|
Nathan D. Jorgensen CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
45,500
+22.06%
|
-
|
|
Feb 06
2023
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
54,500
+50.0%
|
-
|
|
Feb 06
2023
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
47,750
+24.43%
|
-
|